Literature DB >> 25837518

The new lipid guidelines: what do primary care clinicians think?

Sina Jamé1, Eve Wittenberg2, Michael B Potter3, Kirsten E Fleischmann4.   

Abstract

BACKGROUND: Little is known about the opinions of primary care clinicians regarding the newly released 2013 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines for the Prevention of Primary and Secondary Atherosclerotic Disease. This survey was created to assess the awareness, attitudes, and practices of primary care clinicians on adoption of the new guidelines and to explore obstacles to implementation and suggestions for improving shared decision-making.
METHODS: Six hundred practicing clinicians within the San Francisco Bay Area Collaborative Research Network were invited to participate in this cross-sectional, Internet-based pilot survey of primary care clinicians. These survey data were collected in March 2014, approximately 4 months after the release of the new guidelines and 1 month after the release of the ACC/AHA risk estimator application.
RESULTS: One hundred eighty-three clinicians responded to the survey. Of those respondents, 176 (96%) were aware of the guidelines. The majority (64%) reported implementing the new guidelines with at least some of their patients, while a minority (25%) reported adopting the guidelines for many of their patients. Disagreeing with the guidelines was the main hindrance to adoption.
CONCLUSIONS: While many primary care clinicians are aware of the new guidelines, a substantial proportion has yet to implement them into their clinical practice, and obstacles remain for full adoption. Further understanding of clinicians' views, opinions, and needs is necessary to optimize the approach to lipid management and ensure integration into current practice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AHA/ACC guidelines; Cholesterol; Primary care providers

Mesh:

Substances:

Year:  2015        PMID: 25837518      PMCID: PMC4664185          DOI: 10.1016/j.amjmed.2015.02.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

Authors:  Maryam Kavousi; Maarten J G Leening; David Nanchen; Philip Greenland; Ian M Graham; Ewout W Steyerberg; M Arfan Ikram; Bruno H Stricker; Albert Hofman; Oscar H Franco
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

2.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Authors:  Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

3.  Statins, risk assessment, and the new American prevention guidelines.

Authors:  Donald M Lloyd-Jones; David Goff; Neil J Stone
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

4.  Statins: new American guidelines for prevention of cardiovascular disease.

Authors:  Paul M Ridker; Nancy R Cook
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

5.  More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines.

Authors:  John P A Ioannidis
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

6.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

7.  Automated outreach to increase primary adherence to cholesterol-lowering medications.

Authors:  Stephen F Derose; Kelley Green; Elizabeth Marrett; Kaan Tunceli; T Craig Cheetham; Vicki Y Chiu; Teresa N Harrison; Kristi Reynolds; Southida S Vansomphone; Ronald D Scott
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

8.  Application of new cholesterol guidelines to a population-based sample.

Authors:  Michael J Pencina; Ann Marie Navar-Boggan; Ralph B D'Agostino; Ken Williams; Benjamin Neely; Allan D Sniderman; Eric D Peterson
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245

9.  Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility.

Authors:  Marianna Fontana; Perviz Asaria; Michela Moraldo; Judith Finegold; Khalil Hassanally; Charlotte H Manisty; Darrel P Francis
Journal:  Circulation       Date:  2014-04-17       Impact factor: 29.690

  9 in total
  6 in total

1.  Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use.

Authors:  Qing Huang; Michael Grabner; Robert J Sanchez; Vincent J Willey; Mark J Cziraky; Swetha R Palli; Thomas P Power
Journal:  Am Health Drug Benefits       Date:  2016-11

2.  Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelines.

Authors:  H Robert Superko; Paul T Williams; Michael Dansinger; Ernst Schaefer
Journal:  Clin Cardiol       Date:  2018-11-30       Impact factor: 2.882

3.  Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.

Authors:  Yashashwi Pokharel; Lynne Steinberg; Winston Chan; Julia M Akeroyd; Peter H Jones; Vijay Nambi; Khurram Nasir; Laura Petersen; Christie M Ballantyne; Salim S Virani
Journal:  Atherosclerosis       Date:  2016-01-06       Impact factor: 5.162

4.  Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disease.

Authors:  Huimin Zhou; Shaozhao Zhang; Xiuting Sun; Daya Yang; Xiaodong Zhuang; Yue Guo; Xun Hu; Zhimin Du; Meifen Zhang; Xinxue Liao
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors.

Authors:  Samaneh Asgari; Hengameh Abdi; Alireza Mahdavi Hezaveh; Alireza Moghisi; Koorosh Etemad; Hassan Riahi Beni; Davood Khalili
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

6.  Red Cell Distribution Width Is Positively Correlated with Atherosclerotic Cardiovascular Disease 10-Year Risk Score, Age, and CRP in Spondyloarthritis with Axial or Peripheral Disease.

Authors:  Hassan Ahmad; Mariam Khan; Michelle Laugle; Desmond A Jackson; Christopher Burant; Charles J Malemud; Ali D Askari; Maya Mattar; David E Blumenthal; David A Zidar; Donald D Anthony
Journal:  Int J Rheumatol       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.